Authority: High Court of Judicature at Madras

Order Date: 28-08-2026

Case Overview

  • Parties: Plaintiff – Dr. B. Mukesh, Mercury Hospital (Egmore and Velachery, Chennai); Defendant – Dr. V. Mohan, Chairman, Madras Diabetes Research Foundation, Chennai.
  • Proceedings: Application filed under Order VII Rule 11 CPC (A No. 1649 of 2026, CS No. 73 of 2025) seeking rejection of the plaint on grounds of limitation and lack of a real cause of action.
  • Plaint Claims: Compensation of Rs 1,00,00,010 for alleged severe damage to reputation and professional standing; permanent injunction restraining the defendant from publishing, circulating or making any false, defamatory or slanderous statements against the plaintiff through any medium, together with costs.
  • Defendant’s Contentions:
  • The alleged defamatory incidents occurred in 2017 and are barred by the one‑year limitation period under Articles 75 & 76 of the Limitation Act, 1963.
  • The plaintiff relies on an article dated 04‑01‑2025 to create a fresh cause of action; the defendant argues the article is not defamatory and the publisher has not been impleaded.
  • The defendant acted as a whistle‑blower in the public interest, filing complaints before various authorities, and the statements relate to the drug pioglitazone and the plaintiff’s research.
  • An interim injunction (O.A.No.361 of 2025, dated 08‑08‑2025) restraining the defendant was stayed by order dated 11‑02‑2026 in O.S.A.No.382 of 2025; the appeal is pending.
  • Plaintiff’s Counter‑arguments:
  • The defamatory statements were circulated among the academic and medical fraternity, causing embarrassment and injury to reputation.
  • The alleged conduct is not a single incident but a continuing series of publications, including the 04‑01‑2025 article, each constituting a distinct cause of action.
  • Defences such as whistle‑blower protection, fair criticism, or public interest are matters for trial and cannot be considered at the pleading stage.

Court’s Reasoning

1. Under Order VII Rule 11 CPC, the court must examine the averments in the plaint; the defendant’s defence cannot be used to decide whether the plaint discloses a cause of action or is barred by law.

2. The plaint specifically alleges defamatory statements, identifies the persons and sections of the medical community to whom they were communicated, and cites a subsequent publication dated 04‑01‑2025 as part of a continuing course of conduct.

3. Whether the statements are false, defamatory, published to third parties, or caused injury are factual matters requiring evidence; thus the plaint does disclose a cause of action.

4. The limitation period of one year does not automatically bar the suit; the court must determine whether the 04‑01‑2025 publication constitutes a fresh actionable publication, which cannot be decided without evidence.

5. The defendant’s argument that the suit is based solely on 2017 incidents is rejected because the plaintiff also relies on later publications.

6. Issues such as the necessity of joining the article’s publisher, the whistle‑blower claim, and the applicability of defences (truth, fair comment, privilege, public interest) are matters for trial and not for dismissal under Order VII Rule 11.

7. The court notes that while a plaintiff cannot revive a stale claim indefinitely, the determination of whether the later acts are fresh publications requires factual inquiry and cannot be decided at the threshold.

Final Outcome

  • The application filed by the defendant under Order VII Rule 11 (a) & (d) CPC seeking rejection of the plaint in CS No. 73 of 2025 is dismissed.
  • The plaint will proceed to trial for determination of the substantive issues.

Topics: Defamation, Limitation Law, Medical Sector